Fortrea

Fortrea is a global provider of clinical development and patient access solutions to the life sciences industry.

Share price falling

CRO

Fortrea CEO Thomas Pike steps down amid stock free fall

Fortrea’s stock price has been in free fall over the past year—from around $37 per share in May 2024 to around $5 as of 3 p.m. ET Monday.

Darren Incorvaia May 12, 2025 5:00pm

A concept image to illustrate the use of artificial intelligence to improve clinical trials A person in white lab gear and i

Fortrea launches AI R&D arm for clinical trial tech

Jul 1, 2024 2:08pm

handshake deal shake hand arrows ok yes

Fortrea to become 'pure-play' CRO after sale of businesses

Mar 12, 2024 3:35pm

Photo of three hands placing together three white puzzle pieces

Fortrea, Veeva and Advarra in pact to streamline clinical trials

Jan 11, 2024 5:00am

data error magnifying glass inspection mistake

Could a CRO error explain Acelyrin's shocking phase 3 failure?

Nov 28, 2023 5:00am

visual of a diverse set of hands joining together

Fortrea, Medidata ink deal to drive diversity in trials

Nov 21, 2023 10:10am